Coronary

Bivalirudin Is the Most Evidence Based Antithrombin Agent for Primary PCI

Original Broadcast: October 25, 2023

Conference: TCT 2023

Lecturer: Gregg W. Stone

This website uses cookies to ensure you get the best experience on our website. Read More